MedTrace Logo

Correlation of Metabolic Imaging With Immune Markers in NSCLC Candidate to Immunotherapy.

NCT03563482 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 500

Last updated 2022-04-28

No results posted yet for this study

Summary

The purpose of the present study is to prospectively investigate the correlation between the metabolic parameters on FDG-PET before and during immunotherapy treatment with the immune infiltrate and other tissue or circulating markers in a NSCLC patients candidate to immunotherapy.

Conditions

  • Carcinoma, Non-Small-Cell Lung
  • Positron-Emission Tomography
  • Immunotherapy

Interventions

DIAGNOSTIC_TEST

PET scan

Tumor biopsy at baseline; PET scan performed after 8 weeks of treatment

Sponsors & Collaborators

  • Istituto Clinico Humanitas

    lead OTHER

Principal Investigators

  • Egesta Lopci · Istituto Clinico Humanitas

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-01
Primary Completion
2022-12-31
Completion
2022-12-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03563482 on ClinicalTrials.gov